HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Thursday, 7 February 2013

Recent CUAs

Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers. 23 papers were listed this time. Here's a few in our areas of research interest:

Zhu J, Li T, Wang X, et al. Gene-guided Gefitinib switch maintenance therapy for patients with advanced EGFR mutation-positive Non-small cell lung cancer: an economic analysis. BMC Cancer. 2013 Jan 29;13(1):39. [Epub ahead of print] PubMed PMID: 23360224.

Rodríguez-Martínez CE, Sossa-Briceño MP, Castro-Rodriguez JA. Cost- Utility Analysis of the Inhaled Steroids Available in a Developing Country for the Management of Paediatric Patients with Persistent Asthma. J Asthma. 2013 Jan 28. [Epub ahead of print] PubMed PMID: 23356720.

Lintvedt OK, Griffiths KM, Eisemann M, et al. Evaluating the translation process of an internet-based self-help intervention for prevention of depression: a cost-effectiveness analysis. J Med Internet Res. 2013 Jan 23;15(1):e18. PubMed PMID: 23343481.

Wouters H, Thijs V, Annemans L. Cost-effectiveness of dabigatran etexilate in the prevention of stroke and systemic embolism in patients with atrial fibrillation in Belgium. J Med Econ. 2013 Jan 22. [Epub ahead of print] PubMed PMID: 23320796.